Study on the Efficacy and Mechanism of Metabolomics and Bioinformatics on the Treatment of Qi Stagnation and Blood Stasis Coronary Heart Disease by Danshen Injection
Biomedical Chromatography · 2025
DOI: 10.1002/bmc.70120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Lei Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Chengdu University, Chengdu, China. Hauptthemen laut MEDLINE: Metabolomics, Computational Biology, Coronary Disease, Drugs, Chinese Herbal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Sichuan Province 2025 Regional Innovation Cooperation Project, 2024-2026 Higher Education Personnel Training Quality and Teaching Reform Project, Chengdu University CC National Maker Space 2024 Innovation and Entrepreneurship Education Project.
Abstract (Originalsprache)
This study, grounded in traditional Chinese medicine theory, established a QZXY‐CHD model to investigate DSI's impact on vascular endothelial function, inflammatory factors, oxidative stress, and myocardial energy metabolism from a holistic perspective. The results demonstrated that DSI significantly reduced serum levels of ET‐1, MPO, IL‐1β, TNF‐α, MDA, LDH, and CK‐MB, while increasing NO and SOD levels, indicating DSI's ability to inhibit inflammation, mitigate oxidative stress, and protect endothelial and organ functions. Using bioinformatics, we identified differentially expressed genes and metabolic pathways in coronary heart disease and screened diagnostic biomarkers (JDP2, ZFP36, TRAF3IP3, MRPS30, CLEC4D). Non‐targeted metabolomics revealed changes in endogenous metabolites, identifying 73 differential metabolites between the control (Con) and model (Mod) groups, and 75 between the Mod and DSI groups, with 21 key overlapping metabolites. Integrated bioinformatics and metabolomics analysis highlighted critical metabolites such as arachidonic acid, leukotriene B4, linoleic acid, sucrose, D‐glucose, pyroglutamic acid, and palmitic acid, as well as seven key metabolic pathways including arachidonic acid metabolism, linoleic acid metabolism, and galactose metabolism. This combined analysis provides biological evidence for identifying biomarkers of CHD host susceptibility and elucidates the mechanisms by which DSI ameliorates QZXY‐CHD, offering new insights for diagnosis and disease management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Chengdu University, Chengdu, China.
- Faculty of Food and Biological Engineering, Chengdu University, Chengdu, China.
- Institute of Technology Transfer, Chengdu University, Chengdu, China.
ORCID-Profile: Tao Liu
Förderung
- Sichuan Province 2025 Regional Innovation Cooperation Project
- 2024-2026 Higher Education Personnel Training Quality and Teaching Reform Project
- Chengdu University CC National Maker Space 2024 Innovation and Entrepreneurship Education Project
- Project Results of Chengdu University's National Entrepreneurship Training Program for College Students
- Chengdu Economic Development Zone (Longquanyi District) technological innovation research and development project
Zitieren
APA
Wu, L., Feng, M., Peng, Y., Xiang, Y., Liu, R., & Liu, T. (2025). Study on the Efficacy and Mechanism of Metabolomics and Bioinformatics on the Treatment of Qi Stagnation and Blood Stasis Coronary Heart Disease by Danshen Injection. Biomedical Chromatography. https://doi.org/10.1002/bmc.70120
Vancouver
Wu L, Feng M, Peng Y, Xiang Y, Liu R, Liu T. Study on the Efficacy and Mechanism of Metabolomics and Bioinformatics on the Treatment of Qi Stagnation and Blood Stasis Coronary Heart Disease by Danshen Injection. Biomedical Chromatography. 2025. doi:10.1002/bmc.70120
BibTeX
@article{Wu2025,
author = {Wu, Lei and Feng, Mei and Peng, You and Xiang, Yuyang and Liu, Rihui and Liu, Tao},
title = {Study on the Efficacy and Mechanism of Metabolomics and Bioinformatics on the Treatment of Qi Stagnation and Blood Stasis Coronary Heart Disease by Danshen Injection},
journal = {Biomedical Chromatography},
year = {2025},
doi = {10.1002/bmc.70120}
}
EUVIMED